维普中文期刊产品整合服务
9篇 您的检索式:作者名="SIMON RI"
    题名 作者 年代 出处 被引量
1Screening for suicide risk in a brief medicationmanagement appointment显示文摘Simon RI 2012Psychiatry Times2012,29,5:1
2Achieving target refraction after cataract surgery 显示文摘Simon SS Chee YE Haddadin RI 2014Ophthalmology2014,121,2:1
3Immunization with the cysteine proteinase Ldccys1 gene from Leishmania (Leishmania) chagasi and the recombinant Ldccys1 protein elicits protective immune responses in a murine model of visceral leishmaniasis显示文摘Josie Haydée L. Ferreira Luciana Girotto Gentil Suzana Souza Dias Carlos Eduardo C. Fedeli Simone Katz Clara Lúcia Barbiéri 2007Vaccine2007,,5:1
4Sexual exploitation of patients: How it begins before it happens 显示文摘Simon RI 1989Psychiatr Ann1989,19,2:1
5Suppression of endogenous bcl-2 expression by antisense treatment exacerbates ischemic neuronal death显示文摘Chen J Simon RI Nagayama T 2000J Cereb Blood Flow Metab2000,20,:1
6Complex duodenal injures显示文摘IVATURY RR NASSOURA E SIMON RI 1996SCNA1996,76,:1
7Complex Duodenal Injuries显示文摘 Nassoura ZE Simon RI 1996Surg Clin North Am1996,76,4:1
8A- merican thoracic society/centers for disease control and prevention/infectious disease society of America : treatment of tubercu- losis 显示文摘Blumberg HM Burman WJ Chaisson RE Daley CL Etkind SC Friedman LN Fujiwara P Grzemska M Hopewell PC Iseman MD Jasmer RM Koppaka V Menzies RI O'Brien RJ Reves RR Reichman LB Simone PM Starke JR Vernon AA 2003Am J Respir Cirt Care Med2003,167,4:1
9Real-world performance analysis of a novel computational method in the precision oncology of pediatric tumors显示文摘Background The utility of routine extensive molecular profiling of pediatric tumors is a matter of debate due to the high number of genetic alterations of unknown significance or low evidence and the lack of standardized and personalized decision support methods.Digital drug assignment(DDA)is a novel computational method to prioritize treatment options by aggregating numerous evidence-based associations between multiple drivers,targets,and targeted agents.DDA has been validated to improve personalized treatment decisions based on the outcome data of adult patients treated in the SHIVA01 clinical trial.The aim of this study was to evaluate the utility of DDA in pediatric oncology.Methods Between 2017 and 2020,103 high-risk pediatric cancer patients(<21 years)were involved in our precision oncology program,and samples from 100 patients were eligible for further analysis.Tissue or blood samples were analyzed by whole-exome(WES)or targeted panel sequencing and other molecular diagnostic modalities and processed by a software system using the DDA algorithm for therapeutic decision support.Finally,a molecular tumor board(MTB)evaluated the results to provide therapy recommendations.Results Of the 100 cases with comprehensive molecular diagnostic data,88 yielded WES and 12 panel sequencing results.DDA identified matching off-label targeted treatment options(actionability)in 72/100 cases(72%),while 57/100(57%)showed potential drug resistance.Actionability reached 88%(29/33)by 2020 due to the continuous updates of the evidence database.MTB approved the clinical use of a DDA-top-listed treatment in 56 of 72 actionable cases(78%).The approved therapies had significantly higher aggregated evidence levels(AELs)than dismissed therapies.Filtering of WES results for targeted panels missed important mutations affecting therapy selection.Conclusions DDA is a promising approach to overcome challenges associated with the interpretation of extensive molecular profiling in the routine care of high-risk pediatric cancers.Knowledgebase updates enable automatic interpretation of a continuously expanding gene set,a“virtual”panel,filtered out from genome-wide analysis to always maximize the performance of precision treatment planning.Barbara Vodicska Júlia Déri Dóra Tihanyi Edit Várkondi EnikőKispéter Róbert Dóczi Dóra Lakatos Anna Dirner Mátyás Vidermann Péter Filotás Réka Szalkai-Dénes István Szegedi Katalin Bartyik Krisztina Míta Gábor Réka Simon Péter Hauser György Péter Csongor Kiss Miklós Garami István Peták 2023World Journal of Pediatrics2023,19,10:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费